XtalPi Holdings Limited (HKG:2228)

Market Cap	34.08B +45.9%
Revenue (ttm)	893.17M +201.2%
Net Income	137.71M
EPS	0.03
Shares Out	4.30B
PE Ratio	237.24
Forward PE	136.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,642,331
Open	7.97
Previous Close	7.82
Day's Range	7.62 - 8.08
52-Week Range	5.41 - 15.12
Beta	1.32
Analysts	Strong Buy
Price Target	11.63 (+46.84%)
Earnings Date	Aug 27, 2026

About XtalPi Holdings

XtalPi Holdings Limited operates as a research platform company in Mainland China, the United States, and internationally. The company offers XmartChem, an intelligent synthesis workstation which automates the chemical synthesis process; ChemPlus, desktop solid dispensing device; PatSight, an optical chemical structure extraction tool for patents; and XFEP, a software for rapid FEP calculations using cloud computing. It also provides XMolGen, a generative chemistry tool; and drug discovery solutions, such as hit discovery, hit or lead optimizat...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 1,254
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

Financial numbers in CNY

Analyst Summary

According to 5 analysts, the average rating for 2228 stock is "Strong Buy." The 12-month stock price target is $11.63, which is an increase of 46.84% from the latest price.

Price Target

$11.63

(46.84% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error